17/12/2017
Under the Patronage of H.E. Prof. Dr. Maged ElKemary Kafrelsheikh University president & Prof. Dr. Mohey Ebeed; Captain of Egyptian Pharmacists & the Secretary General of
the Union of Arab Pharmacists with sponsor of Pfizer Pharmaceuticals Company , a scientific symposium has been held at Faculty of Pharmacy entitled :” New Strategies of
Drug Discovery & Development “; these in coinciding with the issuance of the Republican decree of establishment of Institute for Drug Discovery & Development”
at Kafrelsheikh University to be the first Institute in Egypt and Arab Countries. The president commented that this Institute will be considered as Neculi
for pharmaceutical manufacturing. Moreover, the president in his speech clarified that will be the first in the field of drug discovery and development in Egypt and the Arab region
pointing out although the presence of pharmaceuticals manufacturing in Egypt , the experience of manufacturing still needs a lot of training and application
of specialized studies of producing raw materials & decrease drug side effects. H.E. Prof. ElKmary continued his speech emphasizing that Pharmaceutical trade
is the second after the arms Trade, where drug is one of the necessary human needs; therefore, manufacturing & development of drugs is considered as an
important axis for Egyptian National Security & a source to increase state resources of hard currency, and as a result of false drug crisis , the idea of establishment
of this institute comes up to have highly qualified and professionals to discover and manufacture, develop raw materials of drugs.
On the other hand, Prof. El Kemary stressed that the strategy of drug
discovery & development is a must; and should overcome the current level to a
production level , as well as marketing
and exporting , whereas, Egypt is considered a very important exporting good
location opening a wide door invading the Arabic and African markets. The
symposium aims to disseminate culture of drug discovery and development among
Academic and industrial organizations , thus , to keep the Egyptian Drug
safety.